The global surrogacy market is expected to reach USD 195.97 billion by 2034, rising from USD 27.21 billion in 2025, at a CAGR of 24.53% from 2025 to 2034. Increasing infertility rates, favorable legal changes, and growing public acceptance alongside innovations in assisted reproductive technologies are accelerating the market’s rapid expansion.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Surrogacy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Surrogacy Market, by Type
8.1.1. Gestational Surrogacy
8.1.1.1. Market Revenue and Forecast
8.1.2. Traditional Surrogacy
8.1.2.1. Market Revenue and Forecast
9.1. Surrogacy Market, by Technology
9.1.1. Intrauterine Insemination (IUI)
9.1.1.1. Market Revenue and Forecast
9.1.2. In-Vitro Fertilization (IVF)
9.1.2.1. Market Revenue and Forecast
9.1.3. Classical/Standard IVF
9.1.3.1. Market Revenue and Forecast
9.1.4. Intracytoplasmic Sperm Injection (ICSI)
9.1.4.1. Market Revenue and Forecast
9.1.5. Others
9.1.5.1. Market Revenue and Forecast
10.1. Surrogacy Market, by Age Group
10.1.1. Below 35 Years
10.1.1.1. Market Revenue and Forecast
10.1.2. 35-37 Years
10.1.2.1. Market Revenue and Forecast
10.1.3. 38-39 Years
10.1.3.1. Market Revenue and Forecast
10.1.4. 40-42 Years
10.1.4.1. Market Revenue and Forecast
10.1.5. 43-44 Years
10.1.5.1. Market Revenue and Forecast
10.1.6. Over 44 Years
10.1.6.1. Market Revenue and Forecast
11.1. Surrogacy Market, by Service Provider
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Fertility Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Others
11.1.3.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Type
12.1.2. Market Revenue and Forecast, by Technology
12.1.3. Market Revenue and Forecast, by Age Group
12.1.4. Market Revenue and Forecast, by Service Provider
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Type
12.1.5.2. Market Revenue and Forecast, by Technology
12.1.5.3. Market Revenue and Forecast, by Age Group
12.1.5.4. Market Revenue and Forecast, by Service Provider
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Type
12.1.6.2. Market Revenue and Forecast, by Technology
12.1.6.3. Market Revenue and Forecast, by Age Group
12.1.6.4. Market Revenue and Forecast, by Service Provider
12.2. Europe
12.2.1. Market Revenue and Forecast, by Type
12.2.2. Market Revenue and Forecast, by Technology
12.2.3. Market Revenue and Forecast, by Age Group
12.2.4. Market Revenue and Forecast, by Service Provider
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Type
12.2.5.2. Market Revenue and Forecast, by Technology
12.2.5.3. Market Revenue and Forecast, by Age Group
12.2.5.4. Market Revenue and Forecast, by Service Provider
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Type
12.2.6.2. Market Revenue and Forecast, by Technology
12.2.6.3. Market Revenue and Forecast, by Age Group
12.2.6.4. Market Revenue and Forecast, by Service Provider
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Type
12.2.7.2. Market Revenue and Forecast, by Technology
12.2.7.3. Market Revenue and Forecast, by Age Group
12.2.7.4. Market Revenue and Forecast, by Service Provider
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Type
12.2.8.2. Market Revenue and Forecast, by Technology
12.2.8.3. Market Revenue and Forecast, by Age Group
12.2.8.4. Market Revenue and Forecast, by Service Provider
12.3. APAC
12.3.1. Market Revenue and Forecast, by Type
12.3.2. Market Revenue and Forecast, by Technology
12.3.3. Market Revenue and Forecast, by Age Group
12.3.4. Market Revenue and Forecast, by Service Provider
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Type
12.3.5.2. Market Revenue and Forecast, by Technology
12.3.5.3. Market Revenue and Forecast, by Age Group
12.3.5.4. Market Revenue and Forecast, by Service Provider
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Type
12.3.6.2. Market Revenue and Forecast, by Technology
12.3.6.3. Market Revenue and Forecast, by Age Group
12.3.6.4. Market Revenue and Forecast, by Service Provider
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Type
12.3.7.2. Market Revenue and Forecast, by Technology
12.3.7.3. Market Revenue and Forecast, by Age Group
12.3.7.4. Market Revenue and Forecast, by Service Provider
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Type
12.3.8.2. Market Revenue and Forecast, by Technology
12.3.8.3. Market Revenue and Forecast, by Age Group
12.3.8.4. Market Revenue and Forecast, by Service Provider
12.4. MEA
12.4.1. Market Revenue and Forecast, by Type
12.4.2. Market Revenue and Forecast, by Technology
12.4.3. Market Revenue and Forecast, by Age Group
12.4.4. Market Revenue and Forecast, by Service Provider
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Type
12.4.5.2. Market Revenue and Forecast, by Technology
12.4.5.3. Market Revenue and Forecast, by Age Group
12.4.5.4. Market Revenue and Forecast, by Service Provider
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Type
12.4.6.2. Market Revenue and Forecast, by Technology
12.4.6.3. Market Revenue and Forecast, by Age Group
12.4.6.4. Market Revenue and Forecast, by Service Provider
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Type
12.4.7.2. Market Revenue and Forecast, by Technology
12.4.7.3. Market Revenue and Forecast, by Age Group
12.4.7.4. Market Revenue and Forecast, by Service Provider
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Type
12.4.8.2. Market Revenue and Forecast, by Technology
12.4.8.3. Market Revenue and Forecast, by Age Group
12.4.8.4. Market Revenue and Forecast, by Service Provider
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Type
12.5.2. Market Revenue and Forecast, by Technology
12.5.3. Market Revenue and Forecast, by Age Group
12.5.4. Market Revenue and Forecast, by Service Provider
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Type
12.5.5.2. Market Revenue and Forecast, by Technology
12.5.5.3. Market Revenue and Forecast, by Age Group
12.5.5.4. Market Revenue and Forecast, by Service Provider
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Type
12.5.6.2. Market Revenue and Forecast, by Technology
12.5.6.3. Market Revenue and Forecast, by Age Group
12.5.6.4. Market Revenue and Forecast, by Service Provider
13.1. IVIRMA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Boston IVF
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Ovation Fertility
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Extraordinary Conceptions
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Bourn Hall International (TVM Capital Healthcare)
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Circle Surrogacy
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Growing Generations
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. New Hope Fertility Clinic
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description